- Home
- CLCO vs TKNO Comparison
CLCO vs TKNO Comparison
Compare CLCO & TKNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLCO
- TKNO
- Stock Information
- Founded
- CLCO 2018
- TKNO 1996
- Country
- CLCO United Kingdom
- TKNO United States
- Employees
- CLCO N/A
- TKNO N/A
- Industry
- CLCO
- TKNO Medicinal Chemicals and Botanical Products
- Sector
- CLCO
- TKNO Health Care
- Exchange
- CLCO Nasdaq
- TKNO Nasdaq
- Market Cap
- CLCO 360.2M
- TKNO 356.4M
- IPO Year
- CLCO N/A
- TKNO 2021
- Fundamental
- Price
- CLCO $6.66
- TKNO $5.18
- Analyst Decision
- CLCO
- TKNO
- Analyst Count
- CLCO 0
- TKNO 0
- Target Price
- CLCO N/A
- TKNO N/A
- AVG Volume (30 Days)
- CLCO 45.1K
- TKNO 390.8K
- Earning Date
- CLCO 08-28-2025
- TKNO 08-07-2025
- Dividend Yield
- CLCO 8.98%
- TKNO N/A
- EPS Growth
- CLCO N/A
- TKNO N/A
- EPS
- CLCO 1.31
- TKNO N/A
- Revenue
- CLCO $320,759,000.00
- TKNO $38,250,000.00
- Revenue This Year
- CLCO $2.03
- TKNO $8.73
- Revenue Next Year
- CLCO N/A
- TKNO $16.53
- P/E Ratio
- CLCO $5.05
- TKNO N/A
- Revenue Growth
- CLCO N/A
- TKNO 3.79
- 52 Week Low
- CLCO $4.51
- TKNO $3.16
- 52 Week High
- CLCO $12.45
- TKNO $10.37
- Technical
- Relative Strength Index (RSI)
- CLCO 45.41
- TKNO 54.38
- Support Level
- CLCO $6.66
- TKNO $4.04
- Resistance Level
- CLCO $6.97
- TKNO $5.31
- Average True Range (ATR)
- CLCO 0.21
- TKNO 0.33
- MACD
- CLCO -0.03
- TKNO 0.10
- Stochastic Oscillator
- CLCO 12.50
- TKNO 85.07
About CLCO Cool Company Ltd.
Cool Co Ltd is a LNG shipping company. The company is engaged in the acquisition, ownership, operation and chartering of liquefied natural gas (LNG) carriers (LNGCs), and the operation of third party fleets under management agreements. The company manages its business through a single operating and reporting segment, the LNG carrier market.
About TKNO Alpha Teknova Inc.
Alpha Teknova Inc provides critical reagents that enable the discovery, development, and production of biopharmaceutical products such as drug therapies, novel vaccines, and molecular diagnostics. Its offer three product types: pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification. It derives key revenue from United States.